 | This articlerelies largely or entirely on asingle source. Relevant discussion may be found on thetalk page. Please helpimprove this article byintroducing citations to additional sources. Find sources: "Methoxydienone" – news ·newspapers ·books ·scholar ·JSTOR(January 2022) |
 | |
| Clinical data | |
|---|---|
| Other names | Methoxygonadiene; 3-Methoxy-17-dehydro-18-methyl-19-nor-δ2,5(10)-testosterone; 13β-Ethyl-3-methoxygona-2,5(10)-dien-17-one; 18-Methyl-19-nor-δ2,5(10)-epiandrosterone 3-methyl ether |
| Routes of administration | By mouth |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C20H28O2 |
| Molar mass | 300.442 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methoxydienone, also known asmethoxygonadiene, as well as3-methoxy-17-dehydro-18-methyl-19-nor-δ2,5(10)-testosterone or13β-ethyl-3-methoxygona-2,5(10)-dien-17-one, is asyntheticanabolic-androgenic steroid (AAS) andprogestogen of the19-nortestosterone group related tolevonorgestrel which was never marketed.[1] It wassynthesized in the 1960s and 1970s bychemistHerchel Smith and his colleagues while they were developingprogestins for use inoral contraceptives.[1] The drug is a potentanabolic when administered viainjection with ananabolic:androgenic ratio of approximately 54:27 relative totestosterone propionate and 90:625 relative tonandrolone.[1] Methoxydienone is not17α-alkylated (instead featuring aketone at the C17 position) and no data exist regarding itsoral activity in humans.[1] It has been sold on theInternet as adesigner steroid.[1]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byadding missing information. |